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Abstract  22 
In vivo tests for male reproductive genotoxicity are time consuming, resource-23 
intensive and their use should be minimised according to the principles of the 3Rs. 24 
Accordingly, we investigated the effects in vitro, of a variety of known, phase-specific 25 
germ cell mutagens, i.e. pre-meiotic, meiotic, and post-meiotic genotoxins, on rat 26 
spermatogenic cell types separated using Staput unit-gravity velocity sedimentation, 27 
evaluating DNA damage using the Comet assay. N-ethyl-N-nitrosourea (ENU), N-28 
methyl-N-nitrosourea (MNU) (spermatogenic phase), 6-mercaptopurine (6-MP) and 29 
5-bromo-2'-deoxy-uridine (5-BrdU) (meiotic phase), methyl methanesulphonate 30 
(MMS) and ethyl methanesulphonate (EMS) (post-meiotic phase) were selected for 31 
use as they are potent male rodent, germ cell mutagens in vivo. DNA damage was 32 
detected directly using the Comet assay and indirectly using the TUNEL assay. 33 
Treatment of the isolated cells with ENU and MNU produced the greatest 34 
concentration-related increase in DNA damage in spermatogonia. Spermatocytes 35 
were most sensitive to 6-MP and 5-BrdU while spermatids were particularly 36 
susceptible to MMS and EMS. Increases were found when measuring both Olive tail 37 
moment (OTM) and % tail DNA, but the greatest changes were in OTM. Parallel 38 
results were found with the TUNEL assay, which showed highly significant, 39 
concentration dependent effects of all these genotoxins on spermatogonia, 40 
spermatocytes and spermatids in the same way as for DNA damage. The specific 41 
effects of these chemicals on different germ cell types matches those produced in 42 
vivo. This approach therefore shows potential for use in the detection of male germ 43 
cell genotoxicity and could contribute to the reduction of the use of animals in such 44 




1. Introduction  47 
The detection and investigation of reproductive toxicants represent one of the major 48 
current challenges in toxicology because of the great number of compounds to be 49 
investigated and the difficulty of testing male germ cells at different phases of their 50 
development (Parodi et al., 2015;  Tralau et al., 2012). A particular problem in germ 51 
cell mutagenicity studies is the relative lack of suitable tools for detecting mutation 52 
induction (Yauk et al., 2015). Historically, studies have utilized huge numbers of 53 
animals in assays such as the morphological specific locus (MSL) test (Russell et al., 54 
1979) and dominant lethal assay (Anderson et al., 1977), to reveal valuable 55 
information about the relative sensitivities male germ cells at different phases of 56 
development (phase-specificity). Nevertheless, there is still a general paucity of 57 
information on how endogenous factors, for example genetic polymorphisms and 58 
exogenous factors such as environmental-toxin exposure, affect the type of germ cell 59 
mutations induced and the risk of their induction (Beal et al., 2012). 60 
In animal tests the rules of the 3 R's: Reduction, Refinement and Replacement 61 
(Russell and Burch, 1959), should be applied in planning and performing 62 
experiments (Flecknell, 2002). Currently, a variety of alternative animal techniques 63 
for assessing the toxicity/genotoxicity of compounds have been developed (Jung et 64 
al., 2015;  Kandarova and Letasiova, 2011). STAPUT methods require far fewer 65 
animals compared with traditional methods thus aiding reduction efforts. Since the 66 
animals are not treated, this refines toxicological approaches. Therefore, because 67 
the uses of STAPUT combine these advantages, its use in a novel toxicity testing 68 
strategy could potentially replace some in vivo testing (Habas et al., 2014). The 69 
present study is a first step in testing this idea. 70 
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There is a growing consensus that the inability to detect mutagens in human germ 71 
cells is the result of technological limitations rather than species differences between 72 
animal and human susceptibility (Beal et al., 2012). Furthermore, hereditary 73 
disorders represent a major cost to health care systems (Directors, 2015). In 74 
addition, there is now longstanding public concern over the genetic consequences of 75 
lifestyle choices and environmental exposures (Chatterjee et al., 2015). Therefore, 76 
there is an urgent need to refine the appropriate germ cell mutagenesis tests and 77 
deepen our understanding of germ cell mutagenesis (Beal et al., 2012). Many 78 
different experimental methods are in use for investigation of genotoxicity of 79 
chemicals in animals (Parasuraman, 2011). There is, for example, increasing interest 80 
in the use of omics technologies to guide the development of biomarker panels to 81 
help predict whether a chemical would elicit a specific response under particular 82 
exposure conditions (Hartung and McBride, 2011;  Wilson et al., 2013).  83 
However, a number of common chemotherapy medications have toxic 84 
consequences for spermatogenesis and can result in a drastic reduction in sperm 85 
count and quality (Dere et al., 2013). Animal models have frequently been used to 86 
assess the toxicity of such drug exposures and such experiments permit researchers 87 
to study the effects on both non-target and target tissue and cell types at a level of 88 
detail which is usually not possible in humans (Dere et al., 2013). In this way, safe 89 
dose levels of chemotherapeutic compounds have been determined in mouse and 90 
rat studies prior to their use in human clinical trials. Even so, the long-term effect of 91 
some of these drugs on fertility and the risk of heritable disease still remain to be 92 
clarified. 93 
Faults in germ cell progression resulting from DNA damage can result in infertility 94 
and the transmission of genetic alterations to the offspring (Anderson et al., 1999;  95 
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Brinkworth, 2000;  Li et al., 2014). Additionally, spermatogenic failure can occur at 96 
different levels, from defective transmigration of primordial germ cells  (PGC), 97 
through spermatogenic arrest and spermatogonial stem cell losses to errors in 98 
spermiogenesis (Jan et al., 2012). All or any of these complications can result in 99 
infertility as a result of azoospermia, severe oligozoospermia and 100 
asthenozoospermia or any combination of these. Indeed infertility can occur also in 101 
the absence of these in normozoospermic men whose semen parameters are 102 
nonetheless normal (Jan et al., 2012). Thus, animal models are currently 103 
indispensable in many areas of reproductive research, not just reproductive genetic 104 
toxicology. The goal of the present work therefore was to explore a novel, in vitro 105 
alternative to in vivo experimentation and determine the extent to which it has the 106 
potential to yield information comparable to that already obtained in extensive, 107 
historical in vivo (dominant lethal) assays, an assay that for many years formed the 108 
bedrock of germline genotoxicity testing (e.g. Anderson et al., 1981;  Ehling et al., 109 
1978;  Topham, 1980).This has been attempted for the Comet assay in vivo 110 
(Hartmann et al., 2013) but not yet with an in vitro approach. 111 
It is well known that ENU and MNU, which are direct-acting alkylating agents 112 
(Beckwith et al., 2000;  Seeley and Faustman, 1995), primarily affect spermatogonia 113 
in vivo (Hitotsumachi et al., 1985;  O'Brien et al., 2015). These alkylating agents 114 
have been found to induce mutagenesis by transferring an ethyl group to 115 
nucleophilic oxygen or nitrogen sites on deoxyribonucleotides, leading to base 116 
mismatch within DNA replication (Imai et al., 2000;  van Boxtel et al., 2010). Russell 117 
et al., (1979) reported that treating male mice with ENU causes mutations that affect 118 
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the spermatogonial stem cells and they also found that the spermatogonia had the 119 
highest rate of mutation in all cell types examined. A high frequency of mutations 120 
was also found in spermatogonial cells after treatment with ENU by others (Katoh et 121 
al., 1994;  Provost and Short, 1994;  Russell et al., 2007). Previous studies showed 122 
that most of the mutations were intragenic after treatment with ENU (Marker et al., 123 
1997;  Miltenberger et al., 2002). In addition, mutations induced by ENU in 124 
spermatogonia, were found to be single base pair changes (Miltenberger et al., 125 
2002). MNU also has been found to be highly mutagenic in differentiating 126 
spermatogonia (Russell et al., 2007;  Russell and Hunsicker, 1983). Spermatogonia 127 
also showed a highly significant increase in genetic damage and apoptosis after 128 
exposure to ENU and MNU (O'Brien et al., 2015). 6-MP and 5-BrdU are considered 129 
to be the major analogue drugs for therapy of acute lymphoblastic leukemia and 130 
autoimmune diseases, and have been used for four decades (Kanemitsu et al., 131 
2009;  Levkoff et al., 2008). 6-MP is metabolized by enzyme activity of thiopurine 132 
methyltransferase (TPMT), and therefore is anabolized by several enzymes to form 133 
6-thioguanine nucleotides, leading to the induction of cytotoxicity as a result of its 134 
incorporation into DNA (Kanemitsu et al., 2009). 6-MP has also been shown to 135 
cause chromosomal damage and aberrations in the spermatocytes of male mice 136 
(Mosesso and Palitti, 1993). It has also been shown that germ cells treated with 6-137 
MP have the greatest response in early meiotic spermatocytes (Generoso et al., 138 
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1975). The thymidine analogue 5-bromo-2′-deoxyuridine (5-BrdU) is a genotoxic 139 
compound that is incorporated into DNA, causing specific-locus mutations and 140 
inhibition of cell proliferation (Morris, 1991). 5-BrdU is a nucleoside analogue 141 
modified via halogen substitution, and its derivatives are widely used in antitumour 142 
agent studies (Kagawa et al., 2008). Histological examination of cultured rat 143 
spermatocytes after injection with 5-BrdU has demonstrated that 5-BrdU mostly 144 
labels spermatocytes (Hue et al., 1998) where it causes a highly significant increase 145 
in DNA damage and apoptosis (Attia, 2012). EMS and MMS are alkylating agents 146 
that represent one of the most important classes of anticancer agents and play a 147 
major role in the treatment of several types of cancers (Chaney and Sancar, 1996;  148 
Kondo et al., 2010). MMS and EMS have been studied in mature spermatozoa to 149 
examine mutagenesis in different phases of spermatogenesis in male mice (van 150 
Delft et al., 1997). It has been found that EMS and MMS induce a high incidence of 151 
dominant lethal mutations in spermatids (Ehling, 1971). They have also been found 152 
to be mutagenic in the last phase of spermatogenesis, i.e. late spermatids and 153 
spermatozoa (van Delft et al., 1997) and to induce chromosomal aberrations, 154 
dominant lethal mutations, and heritable translocations in these cells in mice (Ashby 155 
et al., 1996;  Generoso et al., 1995;  Russell et al., 1992;  Vogel and Nivard, 1997). 156 
2. Materials and Methods  157 
2.1. Animals  158 
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Sexually mature male Sprague-Dawley rats (10-12 weeks old) were obtained from 159 
the Institute of Cancer Therapeutics (ICT), University of Bradford, UK where they 160 
were maintained under standard conditions. All animal care procedures were carried 161 
out according to the National Research Council's Guide for the Care and Use of 162 
Laboratory Animals (2010). 163 
2.2. Chemicals 164 
N-nitroso-N-methylurea (MNU, CAS number 684-93-5), N-ethyl-N-nitrosourea ENU, 165 
CAS number 759-73-9), 5-bromo-2'-deoxy-uridine (5-BrdU, CAS number 59-14-3), 166 
ethyl methanesulphonate (EMS, CAS number 62-50-0) and methyl 167 
methanesulphonate (MMS CAS number 66-27-3) (Sigma Chemical Ltd., Gillingham, 168 
UK) were dissolved in phosphate buffered saline  (pH 7.3 ± 0.2) before treatment, 6-169 
mercaptopurine (6-MP, CAS number 50-44-2) was dissolved in dimethyl sulphoxide 170 
(DMSO) before treatment, and the concentrations were adjusted to (0.05 mM, 0.5 171 
mM and 1.0 mM) when mixed with the cells. 172 
2.3. Cell isolation and culture. 173 
The method for fractionation of rat testicular germ cells was modified from that 174 
described previously for the mouse (Habas et al., 2014). Briefly, four testes were 175 
collected from two adult Sprague-Dawley rats (10-12 weeks old), decapsulated, and 176 
the seminiferous tubules placed into ice cold Dulbecco’s Modified Eagle’s medium 177 
(DMEM), dispersed by gentle pipetting, minced and resuspended in fresh DMEM 178 
containing collagenase (5mg/ml) and DNase (1μg/ml) (both from Sigma, Poole, UK), 179 
then incubated at 32°C for 20 min. The cells were left to stand for 5 min before being 180 
filtered through an 80μm nylon mesh (Tetco Inc., Briarcliff Manor, NY), centrifuged at 181 
600 × g for 10 min and bottom-loaded into the separation chamber of a Staput 182 
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apparatus in a volume of 10ml. A 2-4% w/v concentration gradient of BSA was then 183 
generated below the cells, which were allowed to sediment for a standard period of 184 
2.5h before 31, 12ml fractions were collected at 60s intervals. The cells in each 185 
fraction were examined under a phase contrast microscope, and consecutive 186 
fractions containing cells of similar size and morphology spun down by low-speed 187 
centrifugation and resuspended in DMEM. The identity and purity of all cell 188 
preparations used in the experiments was confirmed by immunohistochemistry and 189 
Western blotting for phase-specific markers exactly as described previously (Habas 190 
et al., 2014). The viabilities of the freshly isolated spermatogonia, spermatocytes 191 
and spermatids were over 98%, as evidenced by trypan blue exclusion of these 192 
cells. Immunocytochemical analysis revealed that the range of purities of the cells 193 
from the spermatogonial fractions was 86% - 90% across the 3 independent 194 
experiments that were performed. For spermatocyte fractions it was 88% - 90% 195 
and 88% - 92% for the spermatid fractions. The results were confirmed by 196 
Western blotting (Figure1 A and B). 197 
Germ cell preparations showed >95% viability as indicated by the trypan blue 198 
exclusion method (Phillips, 1973) at the time of plating, immediately after isolation. 199 
Morphologically normal germ cells were found by examination of cell smears stained 200 
with haematoxylin in the light microscope, and cells from each fraction were counted 201 
on the haemocytometer to determine the number of cells obtained. To determine the 202 
purity of the cell populations, slides with germ cell populations were stained by 203 
immunohistochemistry according to the manufacturer’s instructions, as described 204 
previously (Habas et al., 2014). After determining which fractions contained the 205 
greatest number of each cell type they were pooled and the freshly isolated germ 206 
cells were then washed with PBS and used immediately in the Comet or TUNEL 207 
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assays. The purity of each population was confirmed by Western blot for the 208 
presence or absence of spermatogonia-, spermatocyte- and spermatid-specific 209 
proteins Figure 1A and B. 210 
2.4. Treatment  211 
Germ cell suspensions (1.5-2.5 x 105 cell/ml) were mixed with fresh RPMI medium 212 
(total volume 1000 µl). One hundred μl of mixed germ cells were then added to each 213 
treatment tube (100 μl mixed germ cells, 890 μl RPMI medium, plus 10 μl of 214 
chemical or 900 μl RPMI for the negative control). Cells were treated with different 215 
concentrations (0, 0.05, 0.5, and 1mM) of chemicals at 37°C for 1 h. Solvent controls 216 
were used for the 0 mM dose level. The treated and untreated germ cells were used 217 
in the Comet assay and TUNEL assay.  218 
In vivo data can be used to guide the selection of exposure levels that were used in 219 
vitro according to guidance provided (Guidance, FDA 2005). However, for animal 220 
cells a simple rule of thumb is mg/ml ≡ mg/Kg.bw is based on the principle that 221 
organism are >90 % water.    222 
2.5. Slide preparation 223 
The method described by Anderson et al., (1997) was followed with some 224 
modifications. One hundred μl of 1% low melting agarose (LMP) (Invitrogen, Paisley, 225 
UK: 15517-022) was added to the cell pellet to create a cell suspension. The cell 226 
suspension was transferred to slides pre-coated with 1% normal melting point (NMP) 227 
agarose. The slides were placed on an ice block for 5 min, after which 100 μl of 0.5% 228 
LMP was added on top and slides were placed on ice for 5 min. The slides then were 229 
submerged in cell lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris HCl pH 10.0 230 
containing 1% Triton X-100 and 40 mM dithiothreitol) for 1 h at room temperature 231 
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and protected from light to prevent any light-induced damage. Following this initial 232 
lysis period, proteinase K (Sigma) was added to the lysis solution (final concentration 233 
10μg/ml) and additional lysis was performed at 37°C for 2.5 h (Hughes et al., 1997). 234 
Following lysis, slides were placed in the electrophoresis buffer (0.3 M NaOH, 1 mM 235 
EDTA) for 30 min. 236 
2.6. Unwinding and electrophoresis  237 
The slides were placed on a horizontal gel electrophoresis platform and covered with 238 
an alkaline solution of 300 mM NaOH and 1 mM Na2EDTA. The slides were left in 239 
the solution for 30 min at 4 °C to allow unwinding of the DNA and expression of 240 
alkali-labile sites. The power supply was set at 20 V and 300 mA. The DNA was 241 
electrophoresed for 20 min and the slides rinsed gently 3 times with 400 mM Tris (pH 242 
7.5) to neutralize the excess alkali. Each slide was stained with 50 μl of 20µg/ml 243 
ethidium bromide (Sigma) and covered with a coverslip.  244 
2.7. Examination of cells 245 
Fifty cells per slide per 3 or 4 replicate experiments per treatment group were 246 
analysed at 200X viewing magnification using a fluorescent microscope (Leica, 247 
Wetzlar, Germany) equipped with a BP546/10 excitation filter and a 590 nm barrier 248 
filter. Slides were analysed by a computerized image analysis system (Comet 6.0; 249 
Andor Technology, formerly Kinetic Imaging) Belfast, UK In the Comet assay, Olive 250 
tail moment (OTM) and % tail DNA were measured for isolated germ cells. Comet 251 
tail length is the maximum distance the damaged DNA migrates from the centre of 252 
the cell nucleus, and the OTM is a product of the tail length and the percentage of 253 
tail DNA, which gives a more integrated measurement of overall DNA damage in the 254 
isolated germ cells (Kumaravel and Jha, 2006;  Kumaravel et al., 2009).  255 
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2.8. TUNEL staining and quantitation 256 
DNA fragmentation was examined on the separate cell samples of the same cell 257 
populations by the modified TUNEL method first proposed by Gavrieli et al.  (Gavrieli 258 
et al., 1992) with a commercial apoptosis detection kit (Terminal Deoxynucleotidyl 259 
Transferase Detection Kit; Promega, UK, Ltd). In brief, the coverslips were incubated 260 
with TUNEL reaction mixture (30 mM Tris pH 7.4; 140 mM sodium cacodylate; 1 mM 261 
cobalt chloride; 5 µM biotin-16-deoxyuridine triphosphate; 0.3 U/µl terminal 262 
deoxynucleotidyl transferase [TdT]; all from Sigma) for 60 min (humidity chamber, 263 
37°C) and then washed twice in PBS. (H2O2-blocking of endogenous peroxidases 264 
was not performed as the testis is low in peroxidases so it is rarely necessary.) After 265 
multiple washing steps, the cells were treated with 2% v/v Extravidin peroxidase in 266 
TBS with 0.1% w/v BSA for 30 min (humidity chamber, 37°C), rinsed with PBS, and 267 
visualised by adding 3, 3-diaminobenzine (DAB) for 10 min at room temperature. 268 
Cells were washed in phosphate buffered saline (PBS); each section was 269 
counterstained with haematoxylin then examined and photographed under an 270 
Olympus CKX31 microscope (Olympus, Southend on Sea, UK). For the negative 271 
controls, sections were incubated with the reaction mix without TdT instead of the full 272 
TUNEL reaction mixture. To quantitate the incidence of apoptosis, the three types of 273 
isolated testicular germ cells were evaluated for morphology and staining, The 274 
following findings were considered to represent apoptosis: marked condensation of 275 
chromatin and cytoplasm clearly staining strongly brown or brown/black; The 276 
TUNEL-positive cells were scored in several fields on each coverslip to yield a total 277 
of at least 100 cells under a 40x objective of an Olympus CKX31 microscope. Values 278 
represent percentages from at least 100 cells from each culture. 279 
2.9. Statistical analysis 280 
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Data are expressed as mean ± SEM of at least three independent experiments with 281 
three replicates per experimental group. Comparisons were made by one-way 282 
ANOVA followed by Bonferroni post hoc test; for all experiments, a P value of < 0.05 283 
was considered significant. 284 
3. Results 285 
3.1. Effect of ENU and MNU treatment 286 
MNU and ENU displayed a concentration-response curve in both in vitro assays 287 
used for this investigation. The lowest doses that induced a statistically significant 288 
increase in genetic damage were 0.05 mM ENU and 0.05 mM MNU for DNA 289 
damage and 0.05 mM ENU or 0.05 mM MNU for apoptosis. In spermatogonia, both 290 
the nitrosoureas showed highly increased OTM, % tail DNA and % of apoptotic cells 291 
(Table 1). They were thus clearly much more potent as spermatogonial mutagens 292 
than 6-MP and 5-BrdU or the methanesulphonates (Table 1). The response to ENU 293 
and MNU treatment was also different between the three types of cells analysed: 294 
spermatogonia, showed the highest levels of DNA damage and apoptosis in 295 
response to these genotoxins in comparison to the other types of cells. 296 
Spermatogonial cells showed a clear concentration dependent, statistically 297 
significant increase in comet parameters and apoptosis from the concentration of 298 
0.05 mM upwards (Figures 2 and 4) whereas the other compounds showed lower 299 
means at each dose with generally lower levels of significance and only significant at 300 
all from 0.5 mM upwards.  301 
3.2. Effect of 6-MP and 5-BrdU treatment  302 
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6-MP and 5-Br-dU showed a concentration response-curve in both assays used for 303 
this study. The lowest doses that induced a statistically significant increase in genetic 304 
damage were 0.05 mM 6-MP and 0.05 mM 5-BrdU for DNA damage, and 0.05 mM 305 
6-MP and 0.05 mM 5-BrdU for apoptosis. In spermatocytes, both 6-MP and 5-BrdU 306 
showed highly increased OTM, % tail DNA and the percentage of apoptotic cells. 307 
They were therefore clearly much more potent spermatocyte mutagens than MNU 308 
and ENU or the methanesulphonates (Table 2). The response to 6-MP and 5-BrdU 309 
treatment was also different for the three types of cells analysed with spermatocytes, 310 
showing the highest levels of DNA damage and apoptosis in response to 6-MP and 311 
5-BrdU treatment. Spermatocytes showed a clear concentration-dependent, 312 
statistically significant increase in comet parameters and apoptosis from the 313 
concentration of 0.05 mM upwards (Figure 2, 3 and 4) whereas the other compounds 314 
showed lower means at each dose with generally lower levels of significance and 315 
only significant from 0.5 mM upwards.  316 
3.3. Effect of EMS and MMS treatment 317 
MMS and EMS also showed a concentration-response curve in both assays used for 318 
this study. The lowest concentrations that induced a statistically significant increase 319 
in genetic damage were 0.05 mM MMS or 0.05 mM EMS for DNA damage and 0.05 320 
mM MMS or 0.05 mM EMS for apoptosis. In spermatids, both the 321 
methanesulphonates MMS and EMS showed highly increased OTM, % tail DNA and 322 
the % of apoptotic cells. They were therefore clearly much more potent spermatid 323 
mutagens than MNU and ENU or 6-MP and 5-BrdU (Figure 4). The response to 324 
MMS and EMS treatment was also different for the three types of cells analysed: 325 
spermatids, which showed the highest levels of DNA damage and apoptosis in 326 
response to MMS and EMS treatment than the other types of cells. Spermatocytes 327 
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showed a clear concentration-dependent, statistically significant, increase in comet 328 
parameters and apoptosis from the concentration of 0.05 mM upwards (Figures 2, 3 329 
and 4) whereas the other compounds showed lower means at each dose with 330 
generally lower levels of significance and only significant from 0.5 mM upwards. The 331 
values of various Comet measurements as quantified with Comet 6.0 software 332 
generated from MMS and EMS studies are given in Table 3. The results showed that 333 
OTM and %Tail DNA gave good correlations with the concentration of MMS and 334 
EMS.  335 
4. Discussion  336 
The purpose of this study was to explore the potential for our recently developed in 337 
vitro male germ cell test system (Habas et al., 2014) to detect male germ cell 338 
genotoxins. Furthermore, this type of study could extend our understanding of how 339 
rodent germ cells could be used for monitoring developmental toxicity/genotoxicity 340 
and its relevance to spermatogenic processes. Compositional and metabolic 341 
differences between different types of male germ cells lead to differing 342 
susceptibilities to genotoxicity and mutation induction so the careful analysis of such 343 
phase specificity is important. This can yield valuable information about the potential 344 
mechanisms involved in the toxicity and thus increase the significance of the 345 
findings. This is especially important since mutations induced in the germline can 346 
affect not only the exposed generation but also an unlimited number of generations 347 
thereafter (Verhofstad et al., 2008).The most well-established techniques that have 348 
historically been used to demonstrate that germline mutations appear in the next and 349 
subsequent generations are all very animal-intensive. These include the MSL test 350 
and the dominant lethal test (Verhofstad et al., 2008). In addition, these approaches 351 
have relatively low sensitivity, and are time consuming and expensive (Verhofstad et 352 
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al., 2008).  Nevertheless, these approaches have played a major role in genotoxicity 353 
assessment and in particular, in establishing precise mutation rates associated with 354 
specific exposure levels (MacGregor et al., 2015). 355 
To reduce the number of in vivo assays that detect effects in germ cells and to 356 
adhere to the principles of the 3Rs, in vitro or ex vivo tests should be performed first 357 
(Ouedraogo et al., 2012; Verhofstad et al., 2008).Currently, a variety of alternative 358 
animal techniques for assessing the toxicity/genotoxicity of compounds have been 359 
developed (Jung et al., 2015; Kandarova and Letasiova, 2011). A number of in vitro 360 
assays are currently available such as the detection of chromosome damage or 361 
sister-chromatid exchanges in primary cultures of spermatogonia or spermatocytes 362 
(Perrin et al., 2007). However, these involve low-frequency end-points and are not 363 
suitable for the rapid screening of chemicals for genotoxicity or mutagenicity. 364 
Furthermore, even though it is possible to culture such cells in the presence of 365 
Sertoli cells, there is doubt about how well these germ cells reflect the in vivo 366 
situation, given that they do not have the intimate, all-enveloping contact with the 367 
Sertoli cells found in the seminiferous tubule. The use of cultured Sertoli cells with 368 
testicular germ cells has in fact been used with some success in the past (e.g., (Gray 369 
and Beamand, 1984). However, it has not gained widespread applicability mainly 370 
because of difficulty of reproducing in vitro the tight junctions between Sertoli cells 371 
that form the blood-testis barrier. We have sought to avoid these problems by 372 
culturing the cells for the shortest possible period and to turn the absence of Sertoli 373 
cells (and hence the more direct exposure to chemicals that this affords) into an 374 
advantage by using the system to detect reproductive hazards, rather than for strict 375 
risk assessment. 376 
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Accordingly, we examined DNA-strand breakage and the induction of apoptosis in 377 
short-term, primary cultures of testicular germ cells enriched for spermatogonia, 378 
spermatocytes and spermatids. These were tested using 6 chemicals whose 379 
reproductive genotoxicity is well established and which show clear cell-type 380 
specificity in vivo. Genotoxicity assessment after exposure to ENU, MNU, 6-MP, 5-381 
BrdU and, MMS or EMS was conducted using the alkali version of the Comet assay 382 
to detect DNA strand breaks and the TUNEL assay to detect apoptosis. 383 
Spermatogonia were the most sensitive to ENU and MNU; spermatocytes were most 384 
sensitive to 6-MP and 5-BrdU while spermatids were the most sensitive cell type to 385 
MMS and EMS. Crucially, all these results match the positive results found in vivo 386 
and the cell-type specificity of each chemical found in vivo was the same as that 387 
which we found with our in vitro system. Parallel results were found using the TUNEL 388 
assay, which also showed highly significant, concentration-dependent effects of 389 
these 6 genotoxins on spermatogonia, spermatocytes and spermatids in the same 390 
way as for DNA damage.  391 
In the present study it would appear that the in vitro – in vivo correlation (IVIVC) is 392 
working such that the in vitro concentrations and in vivo absorption directly reflect a 393 
proportional, linear relationship between in vitro (dissolution) and in vivo (fraction 394 
absorbed). This IVIVC has been assumed in all in vitro to in vivo calculations used in 395 
our laboratory and in all cases; the results have revealed a similarly directly 396 
proportional, linear IVIVC for all our in vitro to in vivo extrapolations ( e.g., Anderson 397 
et al., 2003). This implies that in our hands, the in vitro and in vivo systems operate 398 
under comparable kinetics and toxicodynamics. 399 
The results for ENU and MNU are similar to findings by Russell, Hunsicker and 400 
Russell (2007), who also found genetic damage in spermatogonia when treated with 401 
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ENU and MNU. In the present study, comparing the chemicals for the endpoints 402 
studied (i.e., Comet assay and TUNEL assay) revealed that ENU and MNU are 403 
much more effective on spermatogonia than spermatocytes and spermatids. These 404 
results suggest that both chemicals are highly genotoxic in differentiating 405 
spermatogonia, in agreement with in vivo data published previously (Guenet, 2004;  406 
Russell et al., 2007;  Russell and Hunsicker, 1983;  Siepka and Takahashi, 2005). In 407 
addition, increased spontaneous frequency of gene mutations and chromosome 408 
damage has more recently been reported in these cells (O'Brien et al., 2013).  409 
A similar trend was observed in spermatocytes, which showed a highly significant 410 
increase in DNA damage and apoptosis after exposure to 6-MP or 5-BrdU. This 411 
increase was dramatically greater than in spermatids or spermatogonia. Thus, 412 
spermatocytes are the most sensitive to 6-MP and 5-BrdU in agreement with the 413 
findings in vivo that showed 6-MP to be a potent chemical for inducing DNA damage 414 
in spermatocytes (Mosesso and Palitti, 1993) along with 5-BrdU (Perrard et al., 415 
2003). Similarly, Witt and Bishop (1996) have shown that 6-MP induced dominant 416 
lethal mutations specifically in spermatocytes (Witt and Bishop, 1996). 417 
Spermatids were found to be the most sensitive to MMS and EMS in the induction of 418 
genetic damage and apoptosis in agreement with in vivo studies that showed a 419 
decrease in the number of spermatids and a high frequency of chromosome 420 
aberrations induced by these (and other) methanesulphonates in spermatids 421 
(Kuriyama et al., 2005;  Matsuda et al., 1989). 422 
Our work with these chemicals also suggests that OTM and percent tail DNA give 423 
good correlations with the concentration of genotoxic agents used. Statistically, our 424 
results did not find much difference between OTM and % tail DNA. The close 425 
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concordance between the Comet assay and TUNEL assay results is remarkable. 426 
Both assays detect DNA strand breakage but whereas the Comet assay reports 427 
breakage caused by exogenous agents, the TUNEL assay shows strand breaks 428 
induced by endogenous nucleases as part of a cellular suicide mechanism. Such 429 
cellular suicide can be induced by events such as severe DNA-strand breakage so 430 
the results demonstrate effects on two different end-points of genotoxicity, one direct 431 
and one indirect. This demonstrates that multiple end-points can be utilised in our 432 
short-term culture system, even when one is consequent upon another, showing that 433 
the system is flexible enough to be used for mechanistic studies as well as hazard 434 
detection. 435 
The ease and consistency with which our short-term culture system coupled with the 436 
comet and TUNEL assays has detected DNA damage and apoptosis in male rat 437 
germ cells suggests it could have considerable utility for the identification of male 438 
reproductive genotoxins. This is despite the fact that the cells are cultured in the 439 
absence of Sertoli cells. However, it may be that in the absence of any protection 440 
from either the blood-testis barrier or the detoxifying abilities of Sertoli cells, the germ 441 
cells are rendered more susceptible to toxins, thus producing a more sensitive assay 442 
for reproductive genotoxic potential. 443 
5. Conclusion 444 
The level of DNA damage in vitro is dependent on both the gentoxicant and the type 445 
of germ cell, and occurs at concentrations known to be relevant to testicular and 446 
reproductive toxicity in vivo. Furthermore, these results indicate that Staput-isolated 447 
rat testicular germ cells provide a suitable model in vitro to study DNA damage in 448 
different phases of spermatogenesis. The high concordance between the existing in 449 
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vivo data and the present results indicate that this approach should be further 450 
investigated for its potential to detect genetic effects in reproductive cells in vitro with 451 
the long-term aim of enabling a reduction in animal testing for reproductive 452 
genotoxins.  453 
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9. Figure legends 689 
Figure 1. Western blot analysis of Staput-purified germ cells using antibodies for 690 
specific cell-type markers. Figure 1A: Anti-glial cell line-derived neurotrophic factor 691 
receptor (GDNFR) antibody was used to detect spermatogonia (panel B); anti-692 
synaptonemal complex protein 3 (SCP-3) antibody was used to detect 693 
spermatocytes (panel C); anti-transition protein 1 (TP1) antibody (panel D), and the 694 
protein loading control GAPDH is shown in panel A. The relative expression levels of 695 
GDNFR, SPC3 and TP1 were expressed as GDNFR, SCP-3 and TP1/ GAPDH 696 
ratios. Results are the mean ± SEM from four independent experiments. ***p< 0.001. 697 
Figure 1B: Comparison of GDNFR, SCP-3 and TP1 expression in isolated testicular 698 
germ cells. Spermatogonia, spermatocytes, and spermatids were examined by 699 
Western blot analysis. The density of each band was quantified by Image 1.45 700 
software (arbitrary units) and the relative expression levels of GDNFR, SCP-3 and 701 
TP1 was measured by GDNFR, SCP3 and TP1 / GAPDH ratios. Results are the 702 
mean ± SEM. from four independent experiments. ***p < 0.001. 703 
Figure 2. Induced DNA damage in germ cells in the Comet assay after treatment 704 
with ENU, MNU, 6-MP, 5-BrdU, MMS and EMS at different concentrations (0.05 mM, 705 
0.5 mM and 1 mM) for 1h. OTM was used for DNA damage quantification. Data 706 
represent the means ± SE obtained from three independent experiments. *P <0.05, 707 
**P <0.01, *** P <0.001 when compared with the respective control group. 708 
Figure 3. Induced DNA damage in germ cells in the Comet assay after treatment 709 
with ENU, MNU, 6MP, 5BrdU, MMS and EMS at different concentrations (0.05 mM, 710 
0.5 mM and 1 mM) for 1h. %Tail DNA was used for DNA damage quantification. 711 
Data represent the means ± SE obtained from three independent experiments. *P 712 
<0.05, **P <0.01, *** P <0.001 when compared with the respective control group. 713 
Figure 4. Effect of ENU, MNU, 6MP, 5BrdU, MMS and EMS treatment on germ cells 714 
evaluated in the TUNEL assay. Columns represent the mean percentages ± SEM of 715 
apoptotic cells for each of the three concentrations of ENU, MNU, 6-MP, 5-BrdU, 716 
MMS and EMS used (0.05 mM, 0.5 mM and 1 mM). Data represent the means ± SE 717 
obtained from three independent experiments. *P <0.05, **P <0.01, *** P <0.001 718 
when compared with the respective control group.  719 
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Table 1. Individual data for the effects of ENU and MNU on isolated germ cells 720 
measured by the Comet and TUNEL assays. Comet parameters: OTM and % tail 721 
DNA; TUNEL parameter: percentage of apoptotic cells. Data shown represent group 722 
values (mean ± SEM) of three experiments (100 cells scored per experiment). ns not 723 
significant, *p <0.05, **p <0.01 and *** p <0.001 versus control. 724 
 725 
  726 
Germ cells OTM (%)Tail DNA  Apoptotic cells (%) 
Spermatogonia      
Control 1.23 ± 0.06 9.19 ± 0.06  8.00 ± 0.58 
0.05mM ENU 2.33 ± 0.13** 11.45± 0.37** 13.67±0.33** 
0.5mM   ENU 6.21± 0.49 *** 20.64 ± 0.52*** 35.67±0.33*** 
1mM      ENU 9.29 ± 0.20*** 28.38 ± 0.81*** 49.00±0.58*** 
Control 1.03 ± 0.08 6.23 ± 0.33 7.33 ± 0.33 
0.05mM MNU 2.09 ±0.21* 6.86 ± 0.42* 9.00 ± 0.58* 
0.5mM   MNU 5.87 ± 0.65** 20.29±1.51** 16.33 ±  1.20** 
1mM      MNU 8.34 ± 0.28*** 25.10± 0.67** 37.67 ± 1.20*** 
Spermatocytes     
Control 0.91 ± 0.08 3.58  ± 0.36 7.00  ± 0.58 
0.05mM   ENU 1.35 ± 0.23 ns 5.74  ±  0.69 ns 10.00 ± 0.58 ns 
0.5mM     ENU 3.01 ± 0.15 * 10.71± 1.13 * 12.67 ± 0.88 * 
1mM        ENU 3.78 ± 0.21** 14.40 ± 1.12** 19.67 ± 0.67** 
Control 0.72 ± 0.09 3.97 ± 0.37 7.00 ± 0.58 
0.05mM   MNU 1.19 ± 0.20 ns 6.28 ± 0.55 8.33 ± 0.88 
0.5mM     MNU 2.59 ± 0.53 * 11.73 ±1.16 11.00 ± 0.58 
1mM        MNU 3.94 ± 0.43** 14.45 ±1.18 17.00 ± 0.58 
Spermatids    
Control 0.59 ±  0.05 2.77 ±  0.31 6.67 ± 0.33 
0.05mM    ENU 0.75 ±  0.09 ns 5.46 ± 0.95 ns 8.67 ± 0.33 ns 
0.5mM      ENU 1.87 ± 0.37 * 6.24 ± 0.92 * 11.00 ± 0.58* 
1mM         ENU 2.66 ± 0.28** 11.71± 1.20 ** 17.67 ± 0.88** 
Control 0.79 ± 0.08 3.50 ± 0.35 6.67 ± 0.67 
0.05mM    MNU 1.64 ± 0.20 ns 6.15 ± 0.61ns 8.67 ± 1.20 ns 
0.5mM      MNU 2.11± 0.24 * 8.82 ± 0.83 * 12.00 ± 0.58 * 
1mM         MNU 3.02 ± 0.28** 12.46 ±0.84** 17.33 ±0.88** 
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Table 2. Individual data for the effects of 6-MP and 5-BrdU on isolated germ cells 727 
measured by the Comet and TUNEL assays. Comet parameters: OTM and % tail 728 
DNA; TUNEL parameter: percentage of apoptotic cells. Data shown represent group 729 
values (mean ± SEM) of three experiments (100 cells scored per experiment). ns not 730 
significant, *p <0.05, **p <0.01 and *** p <0.001 versus control. 731 
 732 
  733 
Germ cells OTM (%)Tail DNA  Apoptotic cells (%) 
Spermatogonia      
Control 0.80 ± 0.06 3.35 ± 0.33  8.38 ± 0.72 
0.05mM 6-MP 1.20 ± 0.10ns 4.31±  0.30 ns 10.52 ± 1.56 ns 
0.5mM   6-MP 2.63 ± 0.48ns 7.20 ± 0.70 ns 11.14 ± 0.50ns 
1mM      6-MP 3.53 ± 0.38** 11.31± 0.64** 19.73 ±1.43** 
Control 0.80 ± 0.04 3.59 ± 0.13 7.67 ± 0.33 
0.05mM 5-BrdU 1.50 ±0.20ns 6.56 ± 0.89ns  11.00 ± 1.15ns 
0.5mM   5-BrdU 1.88 ± 0.16* 7.66 ± 0.65* 14.33 ± 0.88* 
1mM      5-BrdU 2.80 ± 0.23** 10.34 ± 1.01** 19.00 ± 1.15** 
Spermatocytes     
Control 0.87 ±0.06 3.91± 0.08 7.97 ± 0.50 
0.05mM  6-MP 2.22 ±0.15* 8.50 ±0.67 * 18.11 ± 1.69 * 
0.5mM    6-MP 5.63 ±0.55 ** 12.41 ±0.88 ** 23.47 ± 1.44** 
1mM       6-MP 7.63 ±0.36 *** 19.04 ±0.93 *** 35.33 ± 1.38*** 
Control 0.69 ± 0.04 3.71± 0.35 7.33 ± 0.33 
0.05mM  5-BrdU 1.91±  0.22* 9.36 ± 0.63* 17.00± 1.73* 
0.5mM    5-BrdU 3.88 ± 0.36** 13.09 ± 0.66** 19.00 ± 1.15** 
1mM       5-BrdU 6.55 ± 0.29*** 16.77± 0.79*** 30.66± 1.37*** 
Spermatids    
Control 0.75 ± 0.03 3.81 ± 0.17 6.19 ±  0.58 
0.05mM   6-MP 0.98 ± 0.28ns 5.58 ± 0.90ns 8.21 ± 0.62 ns 
0.5mM     6-MP 1.24 ± 0.13ns 5.87 ± 0.48ns 12.52 ± 1.28 ns 
1mM        6-MP 2.45 ±0.26** 8.60 ± 0.38** 16.27 ± 1.01** 
Control 0.78 ± 0.06 3.69 ± 0.34 5.00 ± 0.58 
0.05mM   5-BrdU 1.43 ± 0.29ns 5.77 ± 0.88 ns 7.00 ± 0.58 ns 
0.5mM     5-BrdU 1.62 ±  0.21* 7.43  ± 1.11* 11.00 ±1.15 * 
1mM        5-BrdU 2.60 ± 0.16** 10.09 ±  0.61** 15.33 ± 0.88** 
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Table 3. Individual data for the effects of MMS and EMS on isolated germ cells 734 
measured by the Comet and TUNEL assays. Comet parameters: OTM and % tail 735 
DNA; TUNEL parameter: percentage of apoptotic cells. Data shown represent group 736 
values (mean ± SEM) of three experiments (100 cells scored per experiment). ns not 737 
significant, *p <0.05, **p <0.01 and *** p <0.001 versus control. 738 
 739 
 740 
  741 
Germ cells OTM (%)Tail DNA  Apoptotic cells (%) 
Spermatogonia      
Control 0.92 ± 0.06 3.96 ± 0.24  8.33  ± 0.33 
0.05mM  MMS 1.69 ± 0.19ns 6.98 ± 1.26ns 11.00 ± 0.58ns 
0.5mM    MMS 2.98 ± 0.53* 9.95 ± 1.37* 13.67 ± 0.6* 
1mM       MMS 4.91 ± 0.48** 16.96 ± 2.04** 21.00 ±1.53** 
Control 1.11 ± 0.16 3.99  ±  0.38 7.33 ± 0.33 
0.05mM  EMS 1.37 ± 0.35 ns 6.15  ±  0.99ns 10.33 ± 0.88ns 
0.5mM    EMS 2.95 ± 0.21* 8.87  ±  0.92* 12.33 ± 0.88* 
1mM       EMS 4.36 ± 0.31** 14.09 ± 1.17** 20.33 ±1.33** 
Spermatocytes     
Control 1.03 ± 0.13 4.59 ± 0.46 7.67 ± 0.67 
0.05mM   MMS 1.77 ± 0.09ns 9.35 ± 0.88 ns 11.33 ± 0.88 ns 
0.5mM     MMS 4.32 ± 0.41* 10.93 ± 0.97* 17.33 ± 0.88* 
1mM        MMS 6.15 ± 0.54** 18.36 ± 1.15** 22.00 ± 1.53** 
Control 0.90 ± 0.09 4.12 ±  0.25 8.00 ± 0.58 
0.05mM   EMS 2.32 ± 0.31ns 9.12  ± 1.18ns 11.33 ± 0.67ns 
0.5mM     EMS 3.44 ± 0.49* 11.41 ±  0.91* 16.67 ± 0.88* 
1mM        EMS 5.17 ± 0.42** 21.81  ± 1.73** 20.67±  0.88** 
Spermatids    
Control 0.89  ± 0.06 4.58± 0.37 7.67 ±  0.67 
0.05mM   MMS 2.65  ± 0.35* 12.34± 0.86* 14.00 ± 0.58* 
0.5mM     MMS 8.02  ± 0.76** 25.44± 0.94** 27.67 ± 1.20** 
1mM        MMS 11.66 ± 1.04*** 36.63 ±0.75*** 35.67 ± 0.88*** 
Control 0.92± 0.03 4.58 ± 0.22 8.00 ±  1.00 
0.05mM   EMS 3.04 ±0.32* 11.06 ± 1.04* 14.00 ± 0.58 * 
0.5mM     EMS 6.80 ±0.85** 24.49 ± 2.10** 20.33 ± 1.86** 
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